Stater Bros. Supermarkets recently announced its decision to distribute several diabetes medications free of charge to diabetes patients throughout the month of November, which is the National Diabetes Awareness Month. The following diabetes medications will be available from all Stater Bros. Super Rx Pharmacy locations, to all diabetes patients, as long as they have a [...]
Takeda Pharmaceuticals North America, Inc., and Takeda Pharmaceuticals Europe Limited, recently issued a joint response regarding the decision taken by the US Food and Drug Administration (FDA) to restrict the use of the drug Avandia (rosiglitazone), in order to allay any fears in patients who were being treated with drugs containing Pioglitazone. Pioglitazone is a [...]
The U.S. Food and Drug Administration (FDA) recently announced its decision to restrict the use of the diabetes drug Avandia (rosiglitazone) to patients with Type 2 diabetes who are unable to control their diabetes using any other medications. This decision was made by the FDA following the results of studies which indicated that the use [...]
The U.S. Food and Drug Administration (FDA) recently announced the commencement of a safety review for Actos (pioglitazone), which is a drug used in the treatment of patients with type 2 diabetes mellitus. This announcement was made following a release of preliminary data from a long term study which aims to assess and evaluate the [...]
The discovery of the fact that the blood levels of some ribonucleic acids (microRNAs) differ between people with type 2 diabetes (as well as those who subsequently develop the disease) and healthy individuals, was published in a recent edition of Circulation Research, a Journal of the American Heart Association. MicroRNAs, which are shorter versions of [...]
TransPharma Medical Ltd recently announced the successful completion of a Phase 1a trial of a drug product being developed for the treatment of diabetes mellitus type II. This new treatment utilizes TransPharma’s proprietary active transdermal drug delivery technology to deliver the GLP1 agonist drug, which regulates glucose metabolism and insulin secretion, into the bloodstream of [...]
The UK’s biggest pharmaceuticals company, GlaxoSmithKline (NYSE:GSK) recently issued a response to an article published in the British Medical Journal (BMJ), regarding the safety of a drug produced by GSK used in the treatment of diabetes, known as rosiglitazone, and sold under the brand name Avandia. Fiona Godlee, The Editor-In-Chief of the BMJ had opined [...]
A medical panel has recommended to the FDA that popular diabetes drug Avandia be withdrawn completely off the market, or have its sales severely restricted. Avandia is manufactured by GlaxoSmithKline, and it’s the trade name for the chemical drug rosiglitazone. Avandia is used by many diabetic patients as it helps their bodies become more sensitive [...]
